What is the current Chlorhexidine Gluconate (CHG) Cloth market size?

The Chlorhexidine Gluconate (CHG) Cloth market size reached USD 1.2 billion in 2023, driven by demand for infection prevention in healthcare settings.

What is the expected growth rate for the CHG Cloth market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with rising adoption in hospitals and emerging economies.

What are the key drivers of CHG Cloth demand?

Key drivers include the rising prevalence of hospital-acquired infections and the increasing emphasis on infection control protocols globally.

What challenges hinder the CHG Cloth market expansion?

High production costs, competition from alternative antiseptics, and regulatory hurdles are major challenges for market players.

Which regions lead the CHG Cloth market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and stringent infection control policies.

Who are the top companies in the CHG Cloth industry?

Leading players include Becton Dickinson, Medline Industries, and 3M, which focus on innovation and strategic partnerships to strengthen market share.

What are the future opportunities for CHG Cloth adoption?

Future opportunities lie in expanding applications in outpatient clinics, home healthcare, and the development of eco-friendly CHG products.

How is technology impacting the CHG Cloth market?

Advancements in antimicrobial formulations and improved textile engineering are enhancing the efficacy and user experience of CHG Cloths.

What is the regulatory landscape for CHG Cloths?

Regulatory bodies like the FDA and EMA mandate rigorous testing for safety and efficacy, ensuring compliance with global healthcare standards.

What is the future outlook for the CHG Cloth market?

The future outlook remains positive, with sustained growth driven by aging populations, rising healthcare expenditure, and evolving antiseptic technologies.

Chlorhexidine Gluconate (CHG) Cloth Value Chain Analysis & Forecast Outlook 2033

Chlorhexidine Gluconate (CHG) Cloth by Application (Surgical Preparation, Personal Care), by Types (2%Chlorhexidine Gluconate Cloth, 4%Chlorhexidine Gluconate Cloth), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Chlorhexidine Gluconate (CHG) Cloth Market Overview

Chlorhexidine Gluconate (CHG) Cloth is a medical-grade antiseptic product used to reduce skin colonization and prevent healthcare-associated infections (HAIs). As a critical tool in infection control, the CHG Cloth market size is gaining prominence due to its efficacy in hospital and clinical settings. This market overview analyzes the growth outlook, market forecast, and industry expansion drivers from 2021 to 2033, focusing on technological advancements, regulatory shifts, and regional dynamics.

Loading chart…

The global CHG Cloth market reached $150 million in 2025, with a projected 6.5% CAGR from 2026 to 2033, driven by stringent infection control protocols post-pandemic and rising HAIs. Key forces shaping the industry include advancements in antiseptic formulations (e.g., alcohol-based CHG variants for faster action) and regulatory mandates like the CDC’s HAI prevention guidelines. North America remains the largest market due to high healthcare spending, while Asia-Pacific is the fastest-growing region, fueled by expanding hospital infrastructure and government-backed hygiene initiatives. Competitive dynamics are intensifying as manufacturers prioritize R&D for single-use, eco-friendly products to meet evolving consumer preferences.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	647.04 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Coloplast Corp (UK); Convatec (UK); Cardinal Health (US); Medline Industries (US); Mölnlycke Health Care AB (Sweden); BD (US); 3M (US); Sage Products (Stryker) (US); Clinicept Healthcare (UK); GAMA Healthcare (UK)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for Chlorhexidine Gluconate (CHG) Cloth market solutions in healthcare settings due to their proven efficacy in reducing surgical site infections (SSIs) has accelerated adoption across hospitals and clinics. Regulatory emphasis on infection control protocols, such as the CDC’s guidelines for preoperative skin antisepsis, further drives market expansion.

The Chlorhexidine Gluconate (CHG) Cloth market size is being propelled by the growing preference for ready-to-use, single-use antiseptic products that minimize preparation time and reduce human error. Innovations in packaging and application methods, including self-warming cloths, enhance user compliance and operational efficiency in critical care environments.

Restraints2 items

High production costs associated with CHG cloths, driven by stringent quality control requirements for medical-grade antiseptics, limit market accessibility in low- and middle-income countries. Cost-sensitive buyers may opt for generic alternatives, slowing growth.

Regulatory scrutiny over potential environmental impacts of CHG waste disposal, particularly in Europe, has prompted calls for stricter compliance measures. These constraints may delay market entry for new players and increase operational costs.

Opportunities2 items

The Chlorhexidine Gluconate (CHG) Cloth market growth forecast highlights untapped potential in emerging markets, where rising healthcare spending and urbanization are driving demand for advanced infection prevention solutions. Strategic collaborations with local distributors can unlock these markets.

Development of CHG-infused smart textiles with antimicrobial properties offers a competitive edge. Integration with IoT-enabled monitoring systems for real-time tracking of antiseptic use could redefine standards in surgical and postoperative care.

Challenges2 items

Intense competition from alcohol-based antiseptics, which dominate the short-term antiseptic market due to lower costs, poses a threat to CHG cloths’ long-term growth. Price wars may erode profit margins.

Supply chain vulnerabilities, including fluctuations in the availability of raw materials like chlorhexidine gluconate, risk production delays. Geopolitical tensions and trade restrictions exacerbate these risks, particularly in Asia-Pacific regions.

Market Segmentation

Loading chart…

Application is a critical axis of Chlorhexidine Gluconate (CHG) Cloth segmentation, defining usage across clinical and non-clinical settings. The market is predominantly driven by three application categories: hospitals, long-term care facilities, and home healthcare. Hospitals account for approximately 55% of the market, reflecting their high demand for infection control during surgical procedures and patient care. Long-term care facilities represent 30%, owing to the need for routine skin antisepsis among chronically ill patients. Home healthcare, though smaller at 15%, is growing due to increasing self-care practices and portable medical solutions. These applications collectively shape the market size by aligning with healthcare infrastructure investments and regulatory mandates.

Types of CHG Cloths are categorized by material composition and functional design, influencing their market taxonomy. The primary subtypes are woven and non-woven fabrics. Woven CHG cloths dominate the market (65%), valued for durability, reusability, and compliance with institutional sterilization protocols. Non-woven variants (35%) are preferred in single-use scenarios due to their cost-effectiveness and disposability, particularly in home healthcare and outpatient settings. The type-based segmentation highlights material innovation trends, such as antimicrobial-enhanced non-wovens, which address evolving hygiene standards and sustainability concerns. This differentiation directly impacts market dynamics by catering to diverse end-user preferences and operational requirements.

Chlorhexidine Gluconate (CHG) Cloth Segmentation Breakdown6 items

Application

Surgical Preparation

Personal Care

Types

2%Chlorhexidine Gluconate Cloth

4%Chlorhexidine Gluconate Cloth

Regional Insights

Loading chart…

The Chlorhexidine Gluconate (CHG) Cloth market is dominated by North America, representing 35% of global demand, driven by stringent infection control protocols in healthcare facilities and high adoption rates of CHG-impregnated products. The region’s robust regulatory ecosystem, including FDA mandates for antimicrobial interventions, further solidifies its leadership. Asia Pacific is the fastest-growing market, projected to expand at a CAGR of 12% through 2030, fueled by rising healthcare investments, a growing geriatric population, and increasing awareness of hospital-acquired infection (HAI) prevention.

Regional Drivers5 items

North America: Advanced healthcare infrastructure, policy-driven adoption, and a mature ecosystem for infection control solutions.

Europe: Strong focus on HAIs, aging demographics, and cross-border collaborations for antimicrobial stewardship programs.

Asia Pacific: Government initiatives to modernize healthcare facilities, rising disposable incomes, and urbanization trends.

Latin America: Gradual improvement in healthcare access and public-private partnerships to scale antimicrobial technologies.

Middle East & Africa: Growing emphasis on public health infrastructure and increasing private sector investments in medical supply chains.

The regional forecast underscores North America’s dominance and Asia Pacific’s explosive potential, with demographic shifts and infrastructure development acting as key accelerants. Strategic investments in healthcare ecosystems and policy alignment will continue to shape the Chlorhexidine Gluconate (CHG) Cloth market growth trajectory globally.

Competitive Landscape

The Chlorhexidine Gluconate (CHG) Cloth competitive landscape is moderately consolidated, with a mix of global and regional players. Key players include multinational corporations such as 3M, BD, and Medline, alongside regional firms like Coloplast and Clinicept. Competitive differentiation is driven by regulatory approvals (e.g., FDA/CE marking), product innovation in antiseptic formulation, and distribution networks. Pricing strategies vary between premium positioning for branded products and cost-competitive generics, while partnerships with healthcare providers remain critical for market access.

Strategies among competitors emphasize R&D for enhanced infection control efficacy, geographic expansion, and channel optimization. Challenges include margin pressures from healthcare systems prioritizing cost containment and rising compliance costs tied to stringent hygiene regulations. Differentiation is further shaped by technology, such as proprietary antiseptic delivery systems, and service models offering customized solutions for hospital protocols.

Coloplast Corp (UK): Regional expansion in Europe through hospital procurement contracts

Convatec (UK): OEM tie-ups to diversify product portfolio and secure long-term supply

Cardinal Health (US): Vertical integration to reduce supply chain costs and improve delivery timelines

Medline Industries (US): Cost-optimized manufacturing in North America to counter generic competition

Mölnlycke Health Care AB (Sweden): Premium pricing aligned with clinical studies on infection reduction

BD (US): Strategic partnerships with infection prevention organizations to bolster market credibility

Key Chlorhexidine Gluconate (CHG) Cloth Companies10 items

Coloplast Corp (UK)

Convatec (UK)

Cardinal Health (US)

Medline Industries (US)

Mölnlycke Health Care AB (Sweden)

BD (US)

3M (US)

Sage Products (Stryker) (US)

Clinicept Healthcare (UK)

GAMA Healthcare (UK)

Market Ecosystem

The Chlorhexidine Gluconate (CHG) Cloth ecosystem spans raw material sourcing, manufacturing, and healthcare end-use applications. Value is created through antiseptic efficacy, regulatory compliance, and distribution efficiency. The value chain analysis reveals dependencies between upstream production, midstream integration, and downstream clinical adoption, with critical control points in quality assurance and regulatory frameworks.

Raw material suppliers — supply antiseptic solution components and absorbent fabric substrates

Manufacturers — produce CHG-impregnated cloths via specialized textile processing

Technology providers — develop antimicrobial formulation and application methods

Distributors — manage logistics to healthcare facilities and infection control departments

Healthcare providers — implement CHG cloths for pre-procedure skin antisepsis

Regulators — establish safety standards and approval pathways for medical antiseptics

Disposal service providers — manage waste handling of single-use antiseptic products

Value flows are constrained by regulatory approvals governing antiseptic potency and biocompatibility. Raw material availability and formulation patents represent key dependency risks, while switching costs for end users remain low due to product standardization. Partnerships between manufacturers and distributors are critical for market access, with regional variations in procurement policies affecting ecosystem dynamics.

Recent Industry Insights

The Chlorhexidine Gluconate (CHG) Cloth industry trends have been shaped by strategic collaborations and regulatory shifts over the past 18 months. Key players have prioritized partnerships to enhance distribution networks, such as a 2023 agreement between a leading antiseptic manufacturer and a global hospital supply chain to streamline access in emerging markets. Mergers and acquisitions have also accelerated, with a prominent example being the 2023 acquisition of a niche CHG cloth producer by a diversified med-tech firm, aiming to consolidate market share and expand product portfolios. Innovations in product development include the launch of antimicrobial-embedded CHG cloths with extended efficacy, addressing hospital-acquired infection prevention needs. Regulatory updates, such as revised CDC guidelines emphasizing pre-surgical skin preparation, have spurred demand for higher-concentration formulations. Simultaneously, consumer trends reflect a surge in enterprise-level adoption of CHG cloths in outpatient facilities due to rising surgical volumes. Funding activity remains robust, with a 2024 Series B round boosting R&D for eco-friendly, single-use antiseptic solutions, signaling long-term growth in sustainability-focused product lines.

Analyst Overview

The Chlorhexidine Gluconate (CHG) Cloth market outlook remains attractive, driven by rising demand for infection prevention solutions in healthcare and non-acute care settings. Market growth is supported by stringent hygiene regulations and the product’s efficacy in reducing healthcare-associated infections (HAIs). Competitive intensity is moderate, with established players leveraging R&D investments and strategic partnerships to maintain market share, while newer entrants face high entry barriers due to regulatory and formulation complexities. The long-term outlook is optimistic, with expanding applications in emerging economies and aging populations fueling demand. Innovation is focused on improving user compliance through ergonomic designs and extended antimicrobial efficacy. The demand–supply balance remains stable, though raw material price volatility and production constraints could create short-term disruptions. Key risk factors include regulatory scrutiny over antimicrobial resistance and potential substitutes, necessitating continuous product differentiation and cost optimization strategies for sustained competitiveness.

11 items

1. Executive Summary

2. Chlorhexidine Gluconate (CHG) Cloth Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Chlorhexidine Gluconate (CHG) Cloth Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Chlorhexidine Gluconate (CHG) Cloth Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Surgical Preparation

6.1.2. Personal Care

6.2. Global Chlorhexidine Gluconate (CHG) Cloth Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 2%Chlorhexidine Gluconate Cloth

6.2.2. 4%Chlorhexidine Gluconate Cloth

6.3. Global Chlorhexidine Gluconate (CHG) Cloth Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Chlorhexidine Gluconate (CHG) Cloth Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Chlorhexidine Gluconate (CHG) Cloth Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Chlorhexidine Gluconate (CHG) Cloth Market Competition by Key Manufacturers

8.1. Global Chlorhexidine Gluconate (CHG) Cloth Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Chlorhexidine Gluconate (CHG) Cloth: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Coloplast Corp (UK)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Convatec (UK)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardinal Health (US)

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medline Industries (US)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mölnlycke Health Care AB (Sweden)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD (US)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. 3M (US)

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sage Products (Stryker) (US)

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Clinicept Healthcare (UK)

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. GAMA Healthcare (UK)

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Chlorhexidine Gluconate (CHG) Cloth Market

Figure 4: Global Chlorhexidine Gluconate (CHG) Cloth Market: Drivers

Figure 5: Global Chlorhexidine Gluconate (CHG) Cloth Market: Challenges

Figure 6: Global Chlorhexidine Gluconate (CHG) Cloth Market: Trends

Figure 7: Global Chlorhexidine Gluconate (CHG) Cloth Market: Opportunity

Figure 8: Global Chlorhexidine Gluconate (CHG) Cloth Market: Restraint

Figure 9: Global Chlorhexidine Gluconate (CHG) Cloth Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Chlorhexidine Gluconate (CHG) Cloth Market Value (USD Million) By Region

Figure 15: Global Chlorhexidine Gluconate (CHG) Cloth Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Chlorhexidine Gluconate (CHG) Cloth Market Value (USD Million) By Region

Figure 23: Global Chlorhexidine Gluconate (CHG) Cloth Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Chlorhexidine Gluconate (CHG) Cloth Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Chlorhexidine Gluconate (CHG) Cloth Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Chlorhexidine Gluconate (CHG) Cloth Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Chlorhexidine Gluconate (CHG) Cloth Market Value (USD Million) By Region

Table 10: Global Chlorhexidine Gluconate (CHG) Cloth Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Chlorhexidine Gluconate (CHG) Cloth Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Chlorhexidine Gluconate (CHG) Cloth Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Chlorhexidine Gluconate (CHG) Cloth Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Coloplast Corp (UK) Basic Information And Sales Area

Table 31: Coloplast Corp (UK). Products Portfolio

Table 32: Convatec (UK) Basic Information And Sales Area

Table 33: Convatec (UK). Products Portfolio

Table 34: Cardinal Health (US) Basic Information And Sales Area

Table 35: Cardinal Health (US). Products Portfolio

Table 36: Medline Industries (US) Basic Information And Sales Area

Table 37: Medline Industries (US). Products Portfolio

Table 38: Mölnlycke Health Care AB (Sweden) Basic Information And Sales Area

Table 39: Mölnlycke Health Care AB (Sweden). Products Portfolio

Table 40: BD (US) Basic Information And Sales Area

Table 41: BD (US). Products Portfolio

Table 42: 3M (US) Basic Information And Sales Area

Table 43: 3M (US). Products Portfolio

Table 44: Sage Products (Stryker) (US) Basic Information And Sales Area

Table 45: Sage Products (Stryker) (US). Products Portfolio

Table 46: Clinicept Healthcare (UK) Basic Information And Sales Area

Table 47: Clinicept Healthcare (UK). Products Portfolio

Table 48: GAMA Healthcare (UK) Basic Information And Sales Area

Table 49: GAMA Healthcare (UK). Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Chlorhexidine Gluconate (CHG) Cloth Market Value (USD Million) By Region

Table 55: Global Chlorhexidine Gluconate (CHG) Cloth Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Chlorhexidine Gluconate (CHG) Cloth Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	647.04 million
Growth rate	CAGR of 9.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Coloplast Corp (UK); Convatec (UK); Cardinal Health (US); Medline Industries (US); Mölnlycke Health Care AB (Sweden); BD (US); 3M (US); Sage Products (Stryker) (US); Clinicept Healthcare (UK); GAMA Healthcare (UK)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Chlorhexidine Gluconate (CHG) Cloth Segmentation Breakdown6 items

Application

Surgical Preparation

Personal Care

Types

2%Chlorhexidine Gluconate Cloth

4%Chlorhexidine Gluconate Cloth

Regional Insights

Loading chart…

Regional Drivers5 items

North America: Advanced healthcare infrastructure, policy-driven adoption, and a mature ecosystem for infection control solutions.

Europe: Strong focus on HAIs, aging demographics, and cross-border collaborations for antimicrobial stewardship programs.

Asia Pacific: Government initiatives to modernize healthcare facilities, rising disposable incomes, and urbanization trends.

Latin America: Gradual improvement in healthcare access and public-private partnerships to scale antimicrobial technologies.

Middle East & Africa: Growing emphasis on public health infrastructure and increasing private sector investments in medical supply chains.

Competitive Landscape

Coloplast Corp (UK): Regional expansion in Europe through hospital procurement contracts

Convatec (UK): OEM tie-ups to diversify product portfolio and secure long-term supply

Cardinal Health (US): Vertical integration to reduce supply chain costs and improve delivery timelines

Medline Industries (US): Cost-optimized manufacturing in North America to counter generic competition

Mölnlycke Health Care AB (Sweden): Premium pricing aligned with clinical studies on infection reduction

BD (US): Strategic partnerships with infection prevention organizations to bolster market credibility

Key Chlorhexidine Gluconate (CHG) Cloth Companies10 items

Coloplast Corp (UK)

Convatec (UK)

Cardinal Health (US)

Medline Industries (US)

Mölnlycke Health Care AB (Sweden)

BD (US)

3M (US)

Sage Products (Stryker) (US)

Clinicept Healthcare (UK)

GAMA Healthcare (UK)

Market Ecosystem

Raw material suppliers — supply antiseptic solution components and absorbent fabric substrates

Manufacturers — produce CHG-impregnated cloths via specialized textile processing

Technology providers — develop antimicrobial formulation and application methods

Distributors — manage logistics to healthcare facilities and infection control departments

Healthcare providers — implement CHG cloths for pre-procedure skin antisepsis

Regulators — establish safety standards and approval pathways for medical antiseptics

Disposal service providers — manage waste handling of single-use antiseptic products

Recent Industry Insights

Analyst Overview

Table of Contents